首站-论文投稿智能助手
典型文献
The miR-23-27-24 cluster:an emerging target in NAFLD pathogenesis
文献摘要:
The incidence of non-alcoholic fatty liver disease(NAFLD)is increasing globally,being the most widespread form of chronic liver disease in the west.NAFLD includes a variety of disease states,the mildest being non-alcoholic fatty liver that gradually progresses to non-alcoholic steatohepatitis,fibrosis,cirrhosis,and eventually hepatocellular carcinoma.Small non-coding single-stranded microRNAs(miRNAs)regulate gene expression at the miRNA or translational level.Numerous miRNAs have been shown to promote NAFLD pathogenesis and progression through increasing lipid accumulation,oxidative stress,mitochondrial damage,and inflammation.The miR-23-27-24 clusters,composed of miR-23a-27a-24-2 and miR-23b-27b-24-1,have been implicated in various biological processes as well as many diseases.Herein,we review the current knowledge on miR-27,miR-24,and miR-23 in NAFLD pathogenesis and discuss their potential significance in NAFLD diagnosis and therapy.
文献关键词:
作者姓名:
Lin Ru;Xiao-mei Wang;Jun-qi Niu
作者机构:
Department of Hepatology,The First Hospital of Jilin University,Changchun 130021,China;Key Laboratory of Zoonosis Research,Ministry of Education,The First Hospital of Jilin University,Changchun 130021,China
引用格式:
[1]Lin Ru;Xiao-mei Wang;Jun-qi Niu-.The miR-23-27-24 cluster:an emerging target in NAFLD pathogenesis)[J].中国药理学报(英文版),2022(05):1167-1179
A类:
mildest
B类:
emerging,target,NAFLD,pathogenesis,incidence,alcoholic,fatty,liver,increasing,globally,being,most,widespread,form,chronic,west,includes,variety,states,that,gradually,progresses,steatohepatitis,fibrosis,cirrhosis,eventually,hepatocellular,carcinoma,Small,coding,single,stranded,microRNAs,miRNAs,regulate,expression,translational,level,Numerous,have,been,shown,promote,progression,through,lipid,accumulation,oxidative,stress,mitochondrial,damage,inflammation,clusters,composed,23a,27a,23b,27b,implicated,various,biological,processes,well,many,diseases,Herein,review,current,knowledge,discuss,their,potential,significance,diagnosis,therapy
AB值:
0.621402
相似文献
Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
Liu Jiaye;Tian Ye;Fu Xia;Mu Chunyang;Yao Menglin;Ni Yinyun;Liu Yong;Li Zhihui-Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610000, China;Respiratory Health Institute, Frontiers Science Center for Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan 610000, China;Department of Outpatients, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Gastroenterological Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。